Recent studies of tumor metabolism identified KRAS-driven alterations in nutrient scavenging and utilization that are critical for the maintenance of PDA tumors8–10, the vast majority of which (>90%) harbor activating KRAS mutations. Here, KRAS is linked to Patent ductus arteriosus.